Showing results (51-60 of 529) with videos related to
Sort By:
Pageof 53
Journal of Chemical Information and Computer Sciences|December 26, 2001
Eigen value analysis of HIV-1 integrase inhibitorsM T Makhija, V M KulkarniPopulation Studies|November 15, 2011
Extrapolation of IUD continuation curvesP M Kulkarni, R G PotterEuropean Journal of Medicinal Chemistry|April 20, 2001
A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitorsR G Karki, V M KulkarniBioorganic & Medicinal Chemistry|November 17, 2001
Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterialsR G Karki, V M KulkarniBioorganic & Medicinal Chemistry|March 12, 2002
QSAR of HIV-1 integrase inhibitors by genetic function approximation methodMahindra T Makhija, Vithal M KulkarniChemotherapy|January 1, 1983
Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparisonV M Kulkarni, J K SeydelJournal of Biomolecular Structure & Dynamics|January 18, 2021
Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitorsSiddharth J Modi, Vithal M KulkarniMolecular and Cellular Biology|April 16, 2005
cis-regulatory logic of short-range transcriptional repression in Drosophila melanogasterMeghana M Kulkarni, David N ArnostiJournal of Computer-Aided Molecular Design|July 15, 2000
Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulationsV M Gokhale, V M KulkarniProteome Science|February 24, 2012
Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancerYogesh M Kulkarni, David J KlinkePageof 53